2022 KEY SPEAKERS
Judge Edger F. Brinkman
Senior Judge Civil Law Division – IP
Court of The Hague, The Netherlands
Professor Willem Hoyng
Partner
HOYNG ROKH MONEGIER
Chairman, Advisory Committee of the UPC
Member, Drafting Committee of the Rules of Proceedings of the UPC
2022 Key Industry Leaders
Sarah Burghart
Lead IP Litigation Counsel
Sandoz
Liz Cohen
Partner
Bristows
Dr. Holger Dulat
VP, Intellectual Property
Affimed
Sarah Hooson
Counsel, Patents
Merck
Guido Pontremoli, Ph.D.
Global IP Head
Chiesi Farmaceutici S.p.A.
Maria Nichol
Head of IP
Agomab Therapeutics
Dr. Corinna Sundermann
Senior Vice President, Intellectual Property Management, Business Center COO
Fresenius Kabi
Dr. Andreas von Falck
Partner
Hogan Lovells
It is a new dawn for European patents. The creation of a new Unified Patent Court and a new patent with unitary effect will fundamentally change the international patent prosecution and litigation landscape for years to come. C5 invites you to the 21st annual Life Sciences IP Summit at a time when the industry is on the precipice of such significant change.
New for 2022
As Europe enters and exciting new era in IP, we are pleased to offer a:
- Spotlight on Patent Prosecution Tools for the New Unitary Patent Era
- Strategy Session for Patent Litigation in the Unified Patent Court
Additional Program Highlights, include:
- Focus Session on Plausibility, Sufficiency, and Inventive Step: Considerations for Formulation, Combination and Second Medical Use Patents
- Tactical Tool-Kit for Claiming Antibody and Epitope Claims
- Update on Priority: Incorporating the Latest Jurisprudence Into Your Patent Prosecution Strategy
- Life Sciences Litigator Think Tank: “What I Wish the Patent Prosecutor Would Have Done”
Testimonials
Another great C5 conference. Good variety of attendees and topics.
Good meeting; I enjoyed it a lot, including both the talks and the social side.
Again, very good speakers from all over Europe and the US.
PAST ATTENDING COMPANIES
- Ablynx NV
- Alkermes Pharma Ireland Ltd
- AstraZeneca AB
- Benitec Biopharma Limited
- Biotronik
- Boehringer Ingelheim
- Celltrion
- Chiesi Farmaceutici Spa
- EGIS Pharmaceuticals PLC
- Esteve Group
- European Patent Office
- F. Hoffmann-La Roche Ltd
- Federal Agency for Nature
- Finnish Patent and Registration Office
- Fresenius Medical Care AG & Co
- Fresenius Medical Care AG & Co. KG Aa
- Geistlich Pharma AG
- Genmab AS
- German Patent & Trade Mark Office
- GlaxoSmithKline
- Groupe Sanofi
- Helsinn Healthcare SA
- JETRO Duesseldorf
- Leukocare AG
- Linde Healthcare
- Merus NV
- Novartis Pharma AG
- Novo Nordisk A/S
- PARI Pharma GmbH
- Patent Office Denmark
- Patents Office Ireland
- Sandoz International GmbH
- Sanofi-Aventis Deutschland GmbH
- Silence Therapeutics Plc
- Swiss Federal Institute of Intellectual Property
- Teva Pharmaceuticals Ltd
- TiGenix NV
- UCB Chong Kun Dang pharm.
- Valea AB
- Zacco Denmark AS
- Zealand Pharma AS
- Zentiva Group
A MUST ATTEND EVENT FOR
Representatives from corporate organisations from functions including:
- Patent Counsel
- Head of IP
- VP-Intellectual Property
- Scientific Director
- Senior IP Counsel
- Associate General Counsel IP
- European Patent Attorney
- Head of Legal Affairs
- Principal Patent Examiner
- Vice President & Chief Counsel – IP
- VP Head Group Intellectual Property
- Head of Global Strategy
- Direct of Patent and Design Rights
- CTO
- Product Manager
- Director Innovation, IP and Portfolio Management
- Director IP Strategy & Projects
- R&D Patent Manager
- Technology Development Manager
- Associate VP & Director of Technology Licensing & Commercialization
Legal Practitioners
- Intellectual Property and Patent
- Life Sciences
- European Patent
- US Patent
